SCHEMBL1372178

SCHEMBL1372178

CCOC(=O)n1nc2c(c1NC(=O)c1ccc(OC)cc1N)CN(S(=O)(=O)c1cc(F)cc(F)c1)C2(C)C

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
IGF1R P08069 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
KMT2A Q03164 3/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
POLB P06746 2/20 0.31
USP2 O75604 1/20 0.31
MITF O75030 1/20 0.30
TP53 P04637 1/20 0.30
GAA P10253 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
RAD52 P43351 1/20 0.30
MAPT P10636 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372652 0.93 USP2 (0.34) ALDH1A1IGF1RKMT2APOLBUSP2
SCHEMBL1373008 0.89 SMN1; SMN2 (0.34) ALDH1A1IGF1RKMT2APOLBUSP2
SCHEMBL1372170 0.89 KDM4E (0.39) ALDH1A1KMT2ANPC1RAB9AUSP2
Hydrochloric Acid SCHEMBL1372982 0.86 ALK (0.42) IGF1RHDAC2
Hydrochloric Acid SCHEMBL4278059 0.86 ALK (0.42) IGF1RHDAC2
SCHEMBL1371041 0.86 NTRK1 (0.37) IGF1RKMT2ATP53GAAMAPT
SCHEMBL1370894 0.82 MAPT (0.38) ALDH1A1IGF1RKMT2ARAB9APOLB
SCHEMBL1373849 0.81 ALDH1A1 (0.40) ALDH1A1KMT2ARAB9APOLBTP53
SCHEMBL4279723 0.81 IGF1R (0.40) IGF1RKMT2AGAAMEN1
SCHEMBL4787339 0.80 IGF1R (0.40) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461193-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-06-11 US disclosed
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.I. (IT) 2011-11-24 US disclosed
US-7968583-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-06-28 US disclosed
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 ALDH1A1 2548/4885IGF1R 737/4885BCHE 4595/4885
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 ALDH1A1 2548/4885IGF1R 737/4885BCHE 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.